Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Corporate Minority | Dead

About Jexys Pharmaceuticals

Provider of proteins. The company operates as a cell-based drug discovery company concentrating on drugs that inhibit MAP Kinase proteins. The drugs could be used in the cure of Rheumatoid Arthritis, as well as of other inflammatory diseases, and cardiovascular diseases. [Keyword: biopharmaceutical]

Jexys Pharmaceuticals Headquarters Location

Givat Ram PO Box: 39024

Jerusalem, 91390,


972 2 658 4718

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

  • Where is Jexys Pharmaceuticals's headquarters?

    Jexys Pharmaceuticals's headquarters is located at Givat Ram, Jerusalem.

  • What is Jexys Pharmaceuticals's latest funding round?

    Jexys Pharmaceuticals's latest funding round is Corporate Minority.

  • Who are the investors of Jexys Pharmaceuticals?

    Investors of Jexys Pharmaceuticals include Teva Pharmaceuticals and Docor International Management.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.